1. Search Result
Search Result
Results for "

Li

" in MedChemExpress (MCE) Product Catalog:

21

Inhibitors & Agonists

1

Biochemical Assay Reagents

1

Peptides

1

Inhibitory Antibodies

4

Natural
Products

23

Recombinant Proteins

9

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-153530

    IPK Superfamily Neurological Disease Metabolic Disease
    LI-2242 is an inositol hexakisphosphate kinase (IP6K) inhibitor. LI-2242 has inhibition effect for IP6K1, IP6K2, IP6K3 and IPMK with IC50 values of 31 nM, 42 nM, 8.7 nM and 1944 nM, respectively. LI-2242 can be used for thew research of type II diabetes, obesity, metabolic complications, venous thrombosis, and psychiatric disorders .
    LI-2242
  • HY-123905A

    Drug Isomer MicroRNA Parasite Infection Cancer
    LIN28 inhibitor LI71 enantiomer is the less active enantiomer of LIN28 inhibitor LI71 (HY-123905). LIN28 inhibitor LI71 is a LIN28 inhibitor that effectively inhibits LIN28:let-7 binding (IC50: 7 μM). LIN28 inhibitor LI71 can abolish LIN28-mediated oligouridylation of let-7 precursor (IC50: 27 μM). LIN28 inhibitor LI71 has potential application value in LIN28-driven cancer research. LIN28 inhibitor LI71 inhibits the interaction of cold shock protein of Plasmodium falciparum (PfCoSP) with DNA and α/β tubulin and has an inhibitory effect on Plasmodium falciparum .
    LIN28 inhibitor LI71 enantiomer
  • HY-123905

    MicroRNA Parasite Infection Cancer
    LIN28 inhibitor LI71 is a LIN28 inhibitor that effectively inhibits LIN28:let-7 binding (IC50: 7 μM). LIN28 inhibitor LI71 can abolish LIN28-mediated oligouridylation of let-7 precursor (IC50: 27 μM). LIN28 inhibitor LI71 has potential application value in LIN28-driven cancer research. LIN28 inhibitor LI71 inhibits the interaction of cold shock protein of Plasmodium falciparum (PfCoSP) with DNA and α/β tubulin and has an inhibitory effect on Plasmodium falciparum .
    LIN28 inhibitor LI71
  • HY-N8207
    Gypenoside LI
    1 Publications Verification

    Apoptosis MicroRNA Cancer
    Gypenoside LI, a gypenoside monomer, possesses anti-tumor activity. Gypenoside LI induces cell apoptosis, cell cycle and migration .
    Gypenoside LI
  • HY-136265

    Aminoacyl-tRNA Synthetase Cancer
    BC-LI-0186 is a potent and selective inhibitor of Leucyl-tRNA synthetase (LRS; LeuRS) and Ras-related GTP-binding protein D (RagD) interaction (IC50=46.11 nM). BC-LI-0186 competitively binds to the RagD interacting site of LRS (Kd=42.1 nM) and has on effects on LRS-Vps34, LRS-EPRS, RagB-RagD association, mTORC1 complex formation or the activities of 12 kinases. BC-LI-0186 can effectively suppress the activity of cancer-associated?MTOR?mutants and the growth of rapamycin-resistant cancer cells.?BC-LI-0186 is a promising agent for lung cancer research .
    BC-LI-0186
  • HY-162821

    IPK Superfamily Neurological Disease
    IP6K-IN-2 (compound 29c) is an orally bioavailable and blood-brain barrier permeable IP6K inhibitor (IC50: 15.8 nM) that can be used in the study of central nervous system diseases .
    LI-3948
  • HY-N2317

    Bisdemethylcurcumin; Li-01008

    Endogenous Metabolite Neurological Disease
    Di-O-demethylcurcumin (Bisdemethylcurcumin) is an intestinal metabolite of curcumin with neuroprotective effects .
    Di-O-demethylcurcumin
  • HY-101817

    Li 32-468; S 32-468; Substance 32468

    Adrenergic Receptor Neurological Disease Endocrinology
    Spirendolol is a β adrenergic receptor antagonist.
    Spirendolol
  • HY-P4040

    HCV Protease Infection Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
    Ac-D-DGla-LI-Cha-C is a potent HCV protease inhibitor peptide. Ac-D-DGla-LI-Cha-C can be used for the research of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases .
    Ac-D-DGla-LI-Cha-C
  • HY-RS04087

    Small Interfering RNA (siRNA) Others

    DYNC2LI1 Human Pre-designed siRNA Set A contains three designed siRNAs for DYNC2LI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    DYNC2LI1 Human Pre-designed siRNA Set A
    DYNC2LI1 Human Pre-designed siRNA Set A
  • HY-RS04085

    Small Interfering RNA (siRNA) Others

    DYNC1LI1 Human Pre-designed siRNA Set A contains three designed siRNAs for DYNC1LI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    DYNC1LI1 Human Pre-designed siRNA Set A
    DYNC1LI1 Human Pre-designed siRNA Set A
  • HY-144256

    DNA/RNA Synthesis Cancer
    CHD1Li 6.11 is a potent oncogenic CHD1L inhibitor (IC50=3.3 µM for cat-CHD1L recombinant protein). CHD1Li 6.11 is an orally bioavailable antitumor agent, significantly reducing the tumor volume of CRC xenografts generated from isolated quasi mesenchymal cells (M-phenotype), which possess enhanced tumorigenic properties .
    CHD1Li 6.11
  • HY-N6984

    Others Metabolic Disease
    Glycyroside is a isoflavone diglycoside isolated from Glycyrrhiza eurycarpa P. C. Li .
    Glycyroside
  • HY-W007656

    Others Others
    Cyclen is a macrocyclic tetraamine. Cyclen is the aza analogue of crown ether, used as a precursor for MRI contrast agents, and is an intermediate for the preparation of effective macrocyclic chelates. Cyclen is employed as a structural regulator through interfacial polymerization of polyethleneimine (PEI) and trimesoyl chloride (TMC) to develop polyamide NF membrane with efficient Li +/Mg 2+ separation performance. Cyclen has specific cavity structure and exhibits selective coordination properties for Li + ions .
    Cyclen
  • HY-148162

    Biochemical Assay Reagents Others
    Kayexalate, a cation-exchange resin, is an orally active plasma potassium inhibitor. Kayexalate can be used in the research of hyperkalemia .
    Kayexalate
  • HY-157914

    6,6-Dibenzyl-1,4,8,11-tetraoxacyclotetradecane

    Biochemical Assay Reagents Others
    Dibenzyl-14-crown-4 (6,6-Dibenzyl-1,4,8,11-tetraoxacyclotetradecane) is a crown ether derivate, which serves as neutral carrier in PVC ion-selective electrode, improves the Li + selectivity against Na + and K + .
    Dibenzyl-14-crown-4
  • HY-W008356

    Drug Intermediate Infection Metabolic Disease
    2-Fluoro-4-iodobenzonitrile is a building block, which can be used to synthesize L. infantum trypanothione reductase (Li-TryR) dimerization and oxidoreductase activity inhibitors. 2-Fluoro-4-iodo benzonitrile can also be used to synthesize transient receptor potential ankyrin 1 (TRPA1) antagonists .
    2-Fluoro-4-iodobenzonitrile
  • HY-126617

    NSC 258308

    Others Cancer
    Duclauxin decreases proliferation of tumor cells in vitro and increases the lifespan of mice innoculated with Ehrlich ascitic tumor cells. Duclauxin (10-30 μg/mL) inhibits mitochondrial respiration of P-388 tumor cells and nucleic acid synthesis in cell culture of Ehrlich cancer, the lymphadenomas NK/LI and L 5178, and sarcoma 37. Duclauxin also inhibits growth of wheat coleoptile.
    Duclauxin
  • HY-113002

    Endogenous Metabolite Metabolic Disease
    α-D-Glucose 1,6-bisphosphate is a bis-phosphorylated derivative of α-D-glucose that has roles in carbohydrate metabolism . It is the product of the reaction of glucose-1- or 6-phosphate with glucose-1,6-bisphosphate synthase (PGM2LI) in the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate . It is also a cofactor for the bacterial enzyme phosphopentomutase [3][4].
    α-D-Glucose 1,6-bisphosphate
  • HY-RS14458

    Small Interfering RNA (siRNA) Others

    TGM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TGM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    TGM1 Human Pre-designed siRNA Set A
    TGM1 Human Pre-designed siRNA Set A
  • HY-P991223

    Transmembrane Glycoprotein TNF Receptor Cancer
    NC762 is a humanized IgG1κ monoclonal antibody that targets human B7-H4 (B7 homolog 4). NC762 has enhanced binding to CD16a (FcγRIIIa) after being Fc engineered with three point mutations (S239D/A330L/I332E; DLE) and demonstrate increased antibody-dependent cellular cytotoxicity (ADCC) activity. NC762 inhibits tumor growth in vivo through binding to tumor-expressing B7-H4. NC762 can be studies in research on cancer such as advanced or metastatic solid tumors .
    NC762

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: